Cancer Progress 2005, the premier cancer conference for executives in the pharmaceutical and biotech community, was held at the Essex House in New York on March 7-8, 2005. Now in its sixteenth year, this conference features distinguished speakers, expansive audience interaction, uncluttered scientific overviews and insightful perspectives on technical and commercial rationales for new avenues of research. Slides from most speakers will be posted on this site shortly. Password access will be provided to all participants.

Cancer therapy remains the most active area of research and development in the pharmaceutical industry. Persistent and innovative efforts are generating an ever- broader understanding of the biological and cellular mechanisms which affect tumor formation, growth and metastasis. Zealous early-stage research  has yielded an unprecedented number of compounds in clinical studies, many of which will dramatically impact the practice and outcome of cancer therapy. Therapeutics that target specific tumor cell populations, interact with key signaling pathways, and selectively interfere with biological growth mechanisms promise to improve treatment efficacy while circumventing peripheral consequences. New programs, franchises and companies are spawning from these efforts.

This hallmark conference assembles leading researchers and clinicians to discuss areas of cancer research which can revolutionize cancer therapy. Presentations are targeted to business development, marketing and R&D executives who are concerned with the big picture in oncology drug research and development. Discussions emphasize the merits, challenges and opportunities of important scientific approaches and project new directions for exploration. Stimulating panels of industry executives, clinicians and analysts spark intriguing discussions of the possibilities and ramifications of specific areas of drug research. Networking is at its height throughout this two-day conference, which includes continental breakfasts, refreshment breaks, luncheons, and a Monday evening cocktail reception. 

Program          Slides from the Conference  (available to participants only)

Conference Sponsors         Communitech